🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/08/2017 2,71 2,77 2,56 2,58 -8,19% 7,75% 1.836.100
24/08/2017 2,25 2,83 2,22 2,81 +26,58% 27,02% 4.943.200
23/08/2017 2,13 2,24 2,08 2,22 +4,72% 7,37% 777.200
22/08/2017 2,05 2,15 2,02 2,12 +4,43% 6,34% 443.900
21/08/2017 2,18 2,18 1,97 2,03 -4,25% 9,63% 773.100
18/08/2017 2,03 2,26 2,00 2,12 +5,47% 12,81% 1.837.600
17/08/2017 1,93 2,05 1,90 2,01 +4,69% 7,77% 843.100
16/08/2017 1,96 1,96 1,90 1,92 -1,03% 3,06% 246.000
15/08/2017 1,95 1,97 1,90 1,94 +0,00% 3,59% 281.200
14/08/2017 1,87 2,00 1,84 1,94 +5,43% 8,56% 640.800
11/08/2017 1,76 1,84 1,72 1,84 +5,14% 6,82% 382.500
10/08/2017 1,84 1,86 1,75 1,75 -4,89% 5,98% 444.300
09/08/2017 1,88 1,95 1,83 1,84 -4,17% 6,38% 681.500
08/08/2017 2,05 2,08 1,88 1,92 -5,88% 9,51% 966.100
07/08/2017 1,84 2,17 1,83 2,04 +10,87% 18,48% 2.919.000
04/08/2017 1,75 1,84 1,65 1,84 +8,24% 10,86% 1.088.800
03/08/2017 1,67 1,74 1,66 1,70 +0,59% 4,79% 463.500
02/08/2017 1,70 1,71 1,63 1,69 -1,74% 4,71% 408.500
01/08/2017 1,75 1,76 1,71 1,72 -2,27% 3,14% 334.800
31/07/2017 1,80 1,81 1,67 1,76 -1,68% 7,78% 772.100
28/07/2017 1,79 1,90 1,69 1,79 -3,24% 11,90% 986.900
27/07/2017 1,85 1,86 1,65 1,85 -1,60% 11,35% 1.439.200
26/07/2017 1,65 1,89 1,63 1,88 +17,50% 15,76% 2.380.800
25/07/2017 1,61 1,63 1,57 1,60 +1,27% 3,60% 286.800
24/07/2017 1,51 1,64 1,51 1,58 +4,64% 8,94% 1.210.400
21/07/2017 1,51 1,55 1,48 1,51 +0,67% 4,64% 349.600
20/07/2017 1,52 1,54 1,50 1,50 -1,32% 2,63% 376.700
19/07/2017 1,51 1,56 1,51 1,52 -0,65% 3,31% 384.600
18/07/2017 1,52 1,56 1,51 1,53 -1,29% 3,29% 415.300
17/07/2017 1,55 1,56 1,51 1,55 +1,97% 3,23% 299.900